Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Life & the Law

Comments Submitted to Dept. of Health and Human Services on Title X Funding

On October 7, the Charlotte Lozier Institute (CLI) filed two separate comments to the Department of Health and Human Services regarding its proposed rule on entities qualifying for the government’s Title X family planning funds. The proposed rule (Compliance with Title X Requirements by Project Recipients in Selecting Subrecipients, 81 FR 61639-61646), which was published September 7, seeks to preclude states from taking action to “restrict participation by certain types of providers as subrecipients in the Title X Program…”

 

The first comment, filed jointly by Alliance Defending Freedom (ADF), Susan B. Anthony List (SBA List), and CLI, clarifies that “certain types of providers” is a “euphemistic way of referring to elective abortion providers such as Planned Parenthood Federation of America affiliates.” In the comment, ADF, SBA List, and CLI maintain that the proposed rule “contradicts the letter and spirit of Title X not to subsidize elective abortion, and runs contrary to the right of States in our federal system to optimize health care for women.”

 

In sum:

Because FQHCs [Federally Qualified Health Centers] and RHCs [Rural Health Centers] provide primary preventive care and access to comprehensive diagnostic care, unlike boutique “reproductive healthcare providers,” prioritizing public healthcare funds to such entities is simply better fiscal healthcare policy. The proposed rule should be withdrawn, and the example of State innovation demonstrated by such prioritization systems should be allowed to continue.

To read the full comment, please see: ADF, SBA List, CLI Comment to Proposed Rule Regarding Title X Requirements.

 

In the second comment that CLI filed jointly with Family Research Council, SBA List, and the March for Life Education and Defense Fund, the groups state their opposition to the proposed rule for the following reasons:

  • the Title X statute does not require states to provide funding to abortion providers;
  • the Title X statute does not preclude grant recipients, including state and local governments, from prioritizing subgrants to organizations that do not perform abortions;
  • the proposed regulation disregards the holistic health care goals of states;
  • HHS’ claims about family planning “effectiveness” lack proper evidence and clear definition; and
  • the proposed HHS regulation itself would undermine health care access and potentially cause a disruption in current healthcare services.

To read the full comment, please see: FRC, SBA List, CLI, March for Life Comment to Proposed Rule Regarding Title X Requirements.

Latest Posts

July 11, 2024 Abortion Reporting: Alaska (2023) July 2, 2024 Experts: No Evidence Behind “Induced Abortion Is Evidence-Based Medical Care” Argument Experts: No Evidence Behind “Induced Abortion Is Evidence-Based Medical Care” Argument July 1, 2024 Is Induced Abortion Evidence-Based Medical Practice?

You Might Also Be Interested In

The State of Abortion Reporting in 2024 America: Still Striving Toward a Better National Standard

June 26, 2024
ClosePlease login

Written Testimony of Dr. Ingrid Skop on Interstate Travel for Abortion

charlotte-lozier-institute Charlotte Lozier Institute
June 18, 2024
ClosePlease login
United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

May 23, 2024
ClosePlease login

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image